Effect of medication on EMG patterns in individuals with Parkinson's disease
Identifieur interne : 004484 ( Main/Exploration ); précédent : 004483; suivant : 004485Effect of medication on EMG patterns in individuals with Parkinson's disease
Auteurs : Julie A. Robichaud [États-Unis] ; Kerstin D. Pfann [États-Unis] ; Cynthia L. Comella [États-Unis] ; Daniel M. Corcos [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2002-09.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (pharmacology), Antiparkinson Agents (therapeutic use), Antiparkinson agent, Chemotherapy, EMG patterns, Electromyography, Electromyography (drug effects), Exploration, Female, Human, Humans, Male, Middle Aged, Motion, Parkinson Disease (drug therapy), Parkinson disease, Parkinson's disease, Time Factors, medication, movement control.
- MESH :
- chemical , pharmacology : Antiparkinson Agents.
- chemical , therapeutic use : Antiparkinson Agents.
- drug effects : Electromyography.
- drug therapy : Parkinson Disease.
- Aged, Female, Humans, Male, Middle Aged, Time Factors.
Abstract
Individuals with Parkinson's disease show dramatic improvements in their ability to move when medicated. However, the neural cause of this improvement is unclear. One hypothesis is that neural activation patterns, as measured by surface electromyography (EMG), are normalized by medication. We tested this hypothesis by investigating the effect of medication on the electromyographic (EMG) patterns recorded when individuals with idiopathic Parkinson's disease performed elbow flexion movements over three movement distances while off and on antiparkinsonian medication. When the subjects were off medication, they lacked the ability to modulate the agonist EMG burst duration with changes in movement distance. The ability to modulate agonist EMG burst duration is characteristic of the EMG patterns observed in healthy subjects. Also, multiple agonist bursts were exhibited during the acceleration phase. As expected, medication diminished the clinical signs of Parkinson's disease, increased movement speed, and increased the magnitude of the first agonist burst. Medication did not restore agonist burst duration modulation with movement distance, did not change the frequency of agonist bursting, and did not alter the timing of the antagonist activation. These results show that medication does not alter the temporal profile of EMG activation. © 2002 Movement Disorder Society
Url:
DOI: 10.1002/mds.10218
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000258
- to stream Istex, to step Curation: 000258
- to stream Istex, to step Checkpoint: 002D75
- to stream PubMed, to step Corpus: 003957
- to stream PubMed, to step Curation: 003957
- to stream PubMed, to step Checkpoint: 003B10
- to stream Ncbi, to step Merge: 000894
- to stream Ncbi, to step Curation: 000894
- to stream Ncbi, to step Checkpoint: 000894
- to stream Main, to step Merge: 006489
- to stream PascalFrancis, to step Corpus: 002626
- to stream PascalFrancis, to step Curation: 000695
- to stream PascalFrancis, to step Checkpoint: 002780
- to stream Main, to step Merge: 006819
- to stream Main, to step Curation: 004484
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect of medication on EMG patterns in individuals with Parkinson's disease</title>
<author><name sortKey="Robichaud, Julie A" sort="Robichaud, Julie A" uniqKey="Robichaud J" first="Julie A." last="Robichaud">Julie A. Robichaud</name>
</author>
<author><name sortKey="Pfann, Kerstin D" sort="Pfann, Kerstin D" uniqKey="Pfann K" first="Kerstin D." last="Pfann">Kerstin D. Pfann</name>
</author>
<author><name sortKey="Comella, Cynthia L" sort="Comella, Cynthia L" uniqKey="Comella C" first="Cynthia L." last="Comella">Cynthia L. Comella</name>
</author>
<author><name sortKey="Corcos, Daniel M" sort="Corcos, Daniel M" uniqKey="Corcos D" first="Daniel M." last="Corcos">Daniel M. Corcos</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:915FB92AA301FDE6D0E2075B8CA207A1DC9EB778</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.10218</idno>
<idno type="url">https://api.istex.fr/document/915FB92AA301FDE6D0E2075B8CA207A1DC9EB778/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000258</idno>
<idno type="wicri:Area/Istex/Curation">000258</idno>
<idno type="wicri:Area/Istex/Checkpoint">002D75</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Robichaud J:effect:of:medication</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12360544</idno>
<idno type="wicri:Area/PubMed/Corpus">003957</idno>
<idno type="wicri:Area/PubMed/Curation">003957</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003B10</idno>
<idno type="wicri:Area/Ncbi/Merge">000894</idno>
<idno type="wicri:Area/Ncbi/Curation">000894</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000894</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Robichaud J:effect:of:medication</idno>
<idno type="wicri:Area/Main/Merge">006489</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:02-0584471</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002626</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000695</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002780</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Robichaud J:effect:of:medication</idno>
<idno type="wicri:Area/Main/Merge">006819</idno>
<idno type="wicri:Area/Main/Curation">004484</idno>
<idno type="wicri:Area/Main/Exploration">004484</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Effect of medication on EMG patterns in individuals with Parkinson's disease</title>
<author><name sortKey="Robichaud, Julie A" sort="Robichaud, Julie A" uniqKey="Robichaud J" first="Julie A." last="Robichaud">Julie A. Robichaud</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Kinesiology, University of Illinois at Chicago, Chicago, Illinois</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Physical Therapy, University of Illinois at Chicago, Chicago, Illinois</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pfann, Kerstin D" sort="Pfann, Kerstin D" uniqKey="Pfann K" first="Kerstin D." last="Pfann">Kerstin D. Pfann</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Kinesiology, University of Illinois at Chicago, Chicago, Illinois</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Comella, Cynthia L" sort="Comella, Cynthia L" uniqKey="Comella C" first="Cynthia L." last="Comella">Cynthia L. Comella</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurological Sciences, Rush Medical Center, Chicago, Illinois</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Corcos, Daniel M" sort="Corcos, Daniel M" uniqKey="Corcos D" first="Daniel M." last="Corcos">Daniel M. Corcos</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Kinesiology, University of Illinois at Chicago, Chicago, Illinois</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Physical Therapy, University of Illinois at Chicago, Chicago, Illinois</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurological Sciences, Rush Medical Center, Chicago, Illinois</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychology, University of Illinois at Chicago, Chicago, Illinois</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-09">2002-09</date>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="950">950</biblScope>
<biblScope unit="page" to="960">960</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">915FB92AA301FDE6D0E2075B8CA207A1DC9EB778</idno>
<idno type="DOI">10.1002/mds.10218</idno>
<idno type="ArticleID">MDS10218</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>EMG patterns</term>
<term>Electromyography</term>
<term>Electromyography (drug effects)</term>
<term>Exploration</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Motion</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Time Factors</term>
<term>medication</term>
<term>movement control</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiparkinson Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Electromyography</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antiparkinsonien</term>
<term>Chimiothérapie</term>
<term>Electromyographie</term>
<term>Exploration</term>
<term>Homme</term>
<term>Mouvement</term>
<term>Parkinson maladie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Individuals with Parkinson's disease show dramatic improvements in their ability to move when medicated. However, the neural cause of this improvement is unclear. One hypothesis is that neural activation patterns, as measured by surface electromyography (EMG), are normalized by medication. We tested this hypothesis by investigating the effect of medication on the electromyographic (EMG) patterns recorded when individuals with idiopathic Parkinson's disease performed elbow flexion movements over three movement distances while off and on antiparkinsonian medication. When the subjects were off medication, they lacked the ability to modulate the agonist EMG burst duration with changes in movement distance. The ability to modulate agonist EMG burst duration is characteristic of the EMG patterns observed in healthy subjects. Also, multiple agonist bursts were exhibited during the acceleration phase. As expected, medication diminished the clinical signs of Parkinson's disease, increased movement speed, and increased the magnitude of the first agonist burst. Medication did not restore agonist burst duration modulation with movement distance, did not change the frequency of agonist bursting, and did not alter the timing of the antagonist activation. These results show that medication does not alter the temporal profile of EMG activation. © 2002 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Illinois</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Illinois"><name sortKey="Robichaud, Julie A" sort="Robichaud, Julie A" uniqKey="Robichaud J" first="Julie A." last="Robichaud">Julie A. Robichaud</name>
</region>
<name sortKey="Comella, Cynthia L" sort="Comella, Cynthia L" uniqKey="Comella C" first="Cynthia L." last="Comella">Cynthia L. Comella</name>
<name sortKey="Corcos, Daniel M" sort="Corcos, Daniel M" uniqKey="Corcos D" first="Daniel M." last="Corcos">Daniel M. Corcos</name>
<name sortKey="Corcos, Daniel M" sort="Corcos, Daniel M" uniqKey="Corcos D" first="Daniel M." last="Corcos">Daniel M. Corcos</name>
<name sortKey="Corcos, Daniel M" sort="Corcos, Daniel M" uniqKey="Corcos D" first="Daniel M." last="Corcos">Daniel M. Corcos</name>
<name sortKey="Corcos, Daniel M" sort="Corcos, Daniel M" uniqKey="Corcos D" first="Daniel M." last="Corcos">Daniel M. Corcos</name>
<name sortKey="Pfann, Kerstin D" sort="Pfann, Kerstin D" uniqKey="Pfann K" first="Kerstin D." last="Pfann">Kerstin D. Pfann</name>
<name sortKey="Robichaud, Julie A" sort="Robichaud, Julie A" uniqKey="Robichaud J" first="Julie A." last="Robichaud">Julie A. Robichaud</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004484 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004484 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:915FB92AA301FDE6D0E2075B8CA207A1DC9EB778 |texte= Effect of medication on EMG patterns in individuals with Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |